Detalles de la búsqueda
1.
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.
Malar J
; 22(1): 2, 2023 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36597076
2.
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria.
Malar J
; 20(1): 222, 2021 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34011358
3.
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
J Infect Dis
; 219(7): 1112-1120, 2019 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30418593
4.
A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.
BMC Med
; 15(1): 181, 2017 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28988541
5.
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Lancet Infect Dis
; 23(9): 1051-1061, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37327809
6.
Bacteremia Among Febrile Ugandan Children Treated with Antimalarials Despite a Negative Malaria Test.
Am J Trop Med Hyg
; 93(2): 276-280, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26055736
Resultados
1 -
6
de 6
1
Próxima >
>>